Posted in Market Access Jazz and Lilly cancer drugs cleared for use by NHS April 21, 2026 Pharmaphorum Jazz’s biliary tract cancer drug Ziihera and Lilly’s Jaypirca for chronic lymphocytic leukaemia have been backed for NHS use in new NICE guidance. Market AccessOncologyRead full story